Stopping treatment suddenly can lead to weight regain GLP-1 medicines help manage appetite, so stopping them quickly can bring back old eating patterns
Patient-reported outcomes in weight loss trials include spontaneous mentions of reduced worry, better sleep quality, and decreased panic-like episodes
change in the taste of food or drink Constipation decreased appetite Diarrhea dizziness gas or burping heartburn mild abdominal pain or bloating nausea redness, itching, or swelling at the injection site tiredness vomiting weight loss Although most of the side effects listed below dont happen very often, they could lead to serious problems if you do not seek medical attention
and Control of Eating Questionnaire scores from the four domains and 19 individual items (applicable for United States and Canada only)
Usage & Storage Description Retatrutide is a novel triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
S.RoohbakhshA